Alternative cutoffs for cortisol post-Dexamethasone suppression testing: is there a practical point for the bone health evaluation?
Background: Current guideline-based stratification in the non-secretory adrenal tumors (ADTs) involves the second-day (post-Dexamethasone testing) plasma cortisol (D-C) threshold of <1.8 μg/dL to determine a non-functional profile and another one for a mild cortisol secretion (cortisol between 1.8 and 5 μg/dL). Objecti...